COMP <GO>
STOK vs QURE // EV/EBITDA & P/E VALUATION
Stoke Therapeutics Inc. (NASDAQ) VS. uniQure N.V. (NASDAQ) • 15-METRIC TALLY: STOK 4
— QURE 1
■ METRIC PARITY
LAST: $26.35 (-0.23%) • MKT CAP: $1.70B
valuation
—
LAST: $25.30 (+1.32%) • MKT CAP: $1.75B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STOK VS. QURE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STOK | QURE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -6.10% | -35.00% | +28.90 | STOK | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.64% | -10.17% | +12.81 | STOK | /fcf-yield <GO> |
| Operating Margin | -11.20% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -3.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 14.79 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | STOK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.3 | 42.4 | +9.88 | STOK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.70B | $1.75B | -$54.7M | QURE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STOK REV | QURE REV | STOK GROSS % | QURE GROSS % | STOK FCF | QURE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $184.4M | $0 | — | — | $44.9M | -$178.4M |
| FY 2024 | $36.6M | $0 | — | — | -$87.1M | -$186.1M |
| FY 2023 | $8.8M | $0 | — | — | -$81.1M | -$145.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STOK // BETA —
QURE // BETA —